{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05424003","recordId":"NCT05424003","peptideSlug":"semaglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05424003-semaglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct05424003.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct05424003.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2022-06-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2022-06-14","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"4d92fb1557c8812739ff4689ac236195b42bc1a7e3243c759da25d77c90e37a3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2022-06-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2022-06-16","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"9f13cfb8d88e52362f62fd68dc3fcbad51013402350f03a5c18cceb9f6aa63ce","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2022-07-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2022-07-22","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"26a53844fc5613813ca47b7434fa21a27723c2edd5e735dd05894de23705e3b2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2022-09-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2022-09-07","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"9825bb7bdf0d04b02b9a3a3fda2ae5c62a0a802e608fe9a052aa6444e9789693","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-09-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2022-09-21","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"e23122720f012609977127e0b73aa131916535988df47dd321f69fcc7a288d11","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2022-10-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2022-10-18","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"c1ce3e188d268c7c9d22438897a5563e3d38798a53743b4221333ba5bbb2df22","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2022-12-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"SUSPENDED","peptideSlug":"semaglutide","submittedDate":"2022-12-12","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"1533b70ebaf6b2bb64af780de8e0dbf3101af4322b317d06012ef1119191cd99","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2023-08-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-08-11","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"c37b5e8c813e1636a4e770f6bf8d28c08d1e4cdaab986a2d85cff43a3ad5c131","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2023-10-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-10-09","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"07104f8d8eea1214a968f90a9c99b70743d04f3cbd6dd658340031edaa72764a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Oversight","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2023-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-10-10","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"bab606dc977c6521095fa707c337cb1201e547d23e3db6f4145b4424457e0838","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-12-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2023-12-04","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"6585d574b9fe83bbebb7b51664073b0f847d7c44f23ee1fb0f2ef54c727bdc11","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-02-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"semaglutide","submittedDate":"2024-02-19","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"b479bd57384cdcb4ae34c9e12d49894a3367c4bd55fa415babb7219832c17d58","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2024-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2024-04-08","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"0b44e4a113a756f8779e6a4e702cbf70d49d7b5dfe79b3aca8a5caef625c3333","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2024-07-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2024-07-26","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"aa4db6c93b0b655211bbbda7e029117684c2e470b7f74c0d3907d4e88ce54464","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2025-07-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2025-07-02","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"cf20bed261bf009e0ad9f41c034f6e8dae27673301f12e1047ae57088e7220ca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-06-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"semaglutide","submittedDate":"2026-06-02","publishedAt":"2026-08-23","recordId":"NCT05424003","recordSha256":"effcac5e0c83cd2aeed8d722dd0880cf924f215ea7f16e0e3505acc513221504","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05424003?a=16&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"48a5a7d1f65bfe6fe61f47ad71866ba3b4bc3a6e734c00cc6f9815c1ff0e918d"}}